Inland Imaging has introduced groundbreaking new therapies to treat prostate and neuroendocrine cancers, bringing innovative theranostic treatments like Pluvicto and Lutathera to patients in the Pacific Northwest region. We’re excited to welcome six new doctors to our subspecialist radiology team, further enhancing our diagnostic capabilities and expanding our capacity to serve patients throughout Eastern Washington, Northern Idaho, and Western Montana.
Additionally, we’ve updated our bone densitometry ordering guidelines to help referring physicians ensure appropriate DXA scan coverage and optimal patient care for osteoporosis screening and bone health assessment.